SS
ATRS

Steve Schonfeld’s Antares Pharma, Inc. ATRS Stock Holding History

Steve Schonfeld’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,847
Closed -$148K – 1770
2020
Q2 		$148K Buy
53,847
+28,847
+115% +$80.5K ﹤0.01% 1143
2020
Q1 		$59K Buy
+25,000
New +$85K ﹤0.01% 1045
2019
Q2 		– Sell
-23,600
Closed -$71K – 1339
2019
Q1 		$71K Buy
+23,600
New +$76.5K ﹤0.01% 996

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Steve Schonfeld's ATRS Position: Q3 2020 in Review

Steve Schonfeld sold out of Antares Pharma, Inc. (ATRS) in Q3 2020, closing a stake of 53,847 shares — an estimated $148K sold.

Steve Schonfeld first reported a position in ATRS in Q1 2019 and held it in 3 quarters. The position peaked at $148K in Q2 2020. 164 funds tracked by Wall St. Rank hold ATRS as of Q3 2020.

  • Steve Schonfeld reported no remaining Antares Pharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Steve Schonfeld sold 53,847 Antares Pharma, Inc. shares in Q3 2020, an estimated $148K.
  • Steve Schonfeld first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 3 quarters.
  • Steve Schonfeld's Antares Pharma, Inc. position peaked at $148K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.